Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimized AAV capsids for basal ganglia diseases show robust potency and distribution.

Nature communications·2025
Same author

Salivary Glands and Viral Pathogenesis.

Journal of dental research·2024
Same author

Using a food web model to predict the effects of Hazardous and Noxious Substances (HNS) accidental spills on deep-sea hydrothermal vents from the Mid-Atlantic Ridge (MAR) region.

Marine pollution bulletin·2024
Same author

The usefulness of ecotoxicological tools to improve the assessment of water bodies in a climate change reality.

The Science of the total environment·2023
Same author

Enteric viruses replicate in salivary glands and infect through saliva.

Nature·2022
Same author

HCV Infection Alters Salivary Gland Histology and Saliva Composition.

Journal of dental research·2022

Related Experiment Video

Updated: Jul 13, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the

B L Davidson1, C S Stein, J A Heth

  • 1Program in Gene Therapy, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242, USA. beverly-davidson@uiowa.edu

Proceedings of the National Academy of Sciences of the United States of America
|February 26, 2000
PubMed
Summary

Recombinant adeno-associated virus serotypes 4 and 5 show distinct central nervous system tropisms compared to serotype 2. These findings highlight potential for improved gene therapy vector development for neurological disorders.

More Related Videos

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2
07:40

Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jul 13, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2
07:40

Widespread Transduction of Mouse Neocortical Neurons by Subarachnoid Injection of AAV2

Published on: May 23, 2025

Area of Science:

  • Neuroscience
  • Gene Therapy
  • Virology

Background:

  • Recombinant adeno-associated virus serotype 2 (rAAV2) vectors are used for central nervous system (CNS) gene transfer.
  • The tropisms of other rAAV serotypes, such as 4 and 5, in the CNS are not well understood.
  • Distinct capsid regions in rAAV4 and rAAV5 suggest different cellular tropisms compared to rAAV2.

Purpose of the Study:

  • To compare the tropisms and transduction efficiencies of rAAV4 and rAAV5 vectors with rAAV2 vectors in the CNS.
  • To investigate the potential of rAAV4 and rAAV5 for CNS gene transfer applications.

Main Methods:

  • In vivo studies using beta-galactosidase (betagal)-encoding vectors derived from rAAV2, rAAV4, and rAAV5.
  • Intraventricular and intrastriatal injections of these vectors in a mouse model.
  • Analysis of transgene expression patterns and cell types transduced.

Main Results:

  • Intraventricular injections of rAAV4 and rAAV5 resulted in significantly higher ependymal cell transduction than rAAV2.
  • Intrastriatal injections of rAAV4 showed ependyma-specific expression with minimal parenchymal transduction.
  • Intrastriatal injections of rAAV5 demonstrated broad transduction of both neurons and astrocytes in the parenchyma, with substantially higher efficiency than rAAV2 over time.

Conclusions:

  • rAAV4 and rAAV5 exhibit distinct CNS cell tropisms compared to rAAV2.
  • These serotypes likely utilize different cellular receptors for entry.
  • The unique tropisms of rAAV4 and rAAV5 offer potential for developing improved gene therapy strategies for CNS disorders.